In the central nervous system obesity-associated inflammation can disrupt leptin hypothalamic action through IKKβ/NFkβ regulation of SOCS-3 (suppressor of cytokine signaling-3), a key inhibitor of leptin signaling [67]. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.